Illuminating drug discovery with biological pathways

被引:82
|
作者
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
关键词
systems biology; drug discovery; biological pathways;
D O I
10.1016/j.febslet.2005.02.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1872 / 1877
页数:6
相关论文
共 50 条
  • [1] Pathways to new drug discovery in neuropsychiatry
    Michael Berk
    BMC Medicine, 10
  • [2] Pathways to new drug discovery in neuropsychiatry
    Berk, Michael
    BMC MEDICINE, 2012, 10
  • [3] A holistic approach for integration of biological systems and usage in drug discovery
    Gupta M.K.
    Misra K.
    Network Modeling Analysis in Health Informatics and Bioinformatics, 2016, 5 (1)
  • [4] Targeting autophagic pathways for cancer drug discovery
    Liu, Bo
    Bao, Jin-Ku
    Yang, Jin-Ming
    Cheng, Yan
    CHINESE JOURNAL OF CANCER, 2013, 32 (03) : 113 - 120
  • [5] Targeting autophagic pathways for cancer drug discovery
    Bo Liu
    JinKu Bao
    JinMing Yang
    Yan Cheng
    ChineseJournalofCancer, 2013, 32 (03) : 113 - 120
  • [6] Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery
    Fernandes, Brisa S.
    Dai, Yulin
    Jia, Peilin
    Zhao, Zhongming
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 61 : 43 - 59
  • [7] Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery
    Fernandes, Brisa S.
    Dai, Yulin
    Jia, Peilin
    Zhao, Zhongming
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 61 : 43 - 59
  • [8] Biological Networks and Drug Discovery-Where Do We Stand?
    Geppert, Tim
    Koeppen, Herbert
    DRUG DEVELOPMENT RESEARCH, 2014, 75 (05) : 271 - 282
  • [9] In vitro Studies of Transendothelial Migration for Biological and Drug Discovery
    Salminen, Alec T.
    Allahyari, Zahra
    Gholizadeh, Shayan
    McCloskey, Molly C.
    Ajalik, Raquel
    Cottle, Renee N.
    Gaborski, Thomas R.
    McGrath, James L.
    FRONTIERS IN MEDICAL TECHNOLOGY, 2020, 2
  • [10] Targeting stem cell signaling pathways for drug discovery:advances in the Notch and Wnt pathways
    AN Songzhu Michael
    DING Qiang
    ZHANG Jie
    XIE JingYi
    LI LingSong
    Science China(Life Sciences) , 2014, (06) : 575 - 580